Descrizione del progetto
Creare un ecosistema interconnesso per il settore biofarmaceutico
L’Industria 4.0 è considerata il biglietto vincente per l’automazione e le tecnologie dei dati. Alimentata dall’Internet delle cose, ha fatto tremare una vasta gamma di settori. Molti stanno cercando di passare rapidamente all’Industria 4.0 per poterne sfruttare i vantaggi. Purtroppo, si tratta di una transizione complessa a causa di costi elevati, mancanza di competenze professionali e altre difficoltà. Il progetto COBIOE, finanziato dall’UE, svilupperà un ecosistema interconnesso per stimolare gli operatori del settore biofarmaceutico a passare all’Industria 4.0. Collaborerà con gli addetti delle catene di valore di bioprodotti in Europa per promuovere una migliore comunicazione e focalizzazione sulle tecnologie verdi e digitali in grado di migliorare la cooperazione e l’efficienza.
Obiettivo
COBIOE is project to interconnect innovation ecosystems to foster 4.0 industrial transition in the biopharmaceutical deeptech sector, sharing competences, information and opportunities, with the aim of ultimately converging toward a common and inclusive European strategy for bioproduction support. Specifically, the proposition will focus on the bioproduction sector that includes development of small molecules, biologics, drugs, innovative therapeutics (such as gene and cellular therapies), high technology drugs based on cell and molecular biology, and covers various applications in health (oncology, immunology, virology, rare diseases, etc…).
COBIOE will reach the following objectives:
- Provide a state of the art and exploitable overview of the European bioproduction value chain, focusing on European, national, regional strategy or existing initiatives, activities
- Opening up the bioproduction field, by reaching out to isolated actors and territories bringing added value to the chain.
- Building up bridges between sparse innovative ecosystems and initiatives opening up opportunities for isolated players.
- Promote bioproduction ecosystems, the field and its potentialities in terms of green, digital and social transition, among various stakeholders and policymakers
COBIOE proposal includes 5 health clusters/networks, preeminent and pioneers in the field of pharmaceutical biomanufacturing. Each partner complements each other in terms of competence and the partnership covers almost all European regions from north to south and east to west, including modest, moderate, strong and leading innovators. Moreover, each partner benefits from an extended network of stakeholders, from different technological sectors (materials science, artificial intelligence, biotechnology, blockchain, robotics, photonics, electronics and quantum information) and actors (universities, research, hospitals, funders…).
Campo scientifico
- natural sciencescomputer and information sciencesartificial intelligence
- natural sciencesbiological sciencesmicrobiologyvirology
- natural sciencescomputer and information sciencescomputer securitycryptography
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringrobotics
- natural sciencesbiological sciencesmolecular biology
Parole chiave
Programma(i)
Argomento(i)
Meccanismo di finanziamento
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinatore
91030 Evry
Francia
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.